Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eleutherococcus senticosus, commonly known as Siberian ginseng or Ciwujia, is a woody shrub in the family Araliaceae widely utilized in Traditional Chinese Medicine (TCM) as an adaptogen. It is primarily used to enhance physical and mental performance and increase resistance to environmental stressors. In clinical research, it is being evaluated for the treatment of insomnia disorder, particularly when associated with the TCM pattern of heart and spleen deficiency syndrome. The pharmacological activity of Eleutherococcus senticosus is attributed to a group of glycosides known as eleutherosides (notably eleutheroside B and E), which are thought to modulate the hypothalamic-pituitary-adrenal (HPA) axis and exert neuroprotective, anti-fatigue, and sedative-hypnotic effects through the potential modulation of GABAergic and serotonergic neurotransmitter systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eleutherococcus senticosus.